Ledger.Open graph →

SEC Form D · Amendment · filed November 10, 2022

General Oncology, Inc

Offering

$3.8M

Sold

$3.2M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BURLINGTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Arnold Glazier · Burlington, MAExec · Director Michael D. Sigman · Burlington, MADirector Gregg Goldstein · Burlington, MAExec · Director Jeffrey A. Glazier · Burlington, MAExec Michael J. Petit · Burlington, MADirector John A. Mitchell · Weddington, NCExec Tony A. Fusco · Weddington, NCExec · Director Arora A. Govind · Weddington, NCDirector Michael O'Leary · Uniondale, NYDirector Jeffrey J. Teplitzky · Woodbridge, CTExec · Director Ryan Friend · San Francisco, CAExec · Director Vanessa J. Gilman · Grand Cayman, Cayman IslandsExec James J. Kattan · Grand Cayman, Cayman IslandsExec · Director James J. Kattan · Grand Cayman, Cayman IslandsDirector Vanessa J. Gilman · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗